The PhysioMimix Organ-on-Chip platform enables researchers to work with a wide range of cell types (iPSCs, primary cells, etc.) and commercial inserts to mimic human physiology in vitro. This improves the efficiency of preclinical studies or industrial screening that require reliable human-relevant data.
Detect potential side effects and toxicity markers before the drugs are tested in humans
- Predict whether a drug that is intended to treat one organ will have adverse effects on another
- Enhance or replace animal studies with more human-relevant in vitro models
- Explore diagnostic and precision medicine applications